SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-17-002931
Filing Date
2017-05-10
Accepted
2017-05-10 16:57:42
Documents
7
Period of Report
2017-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_050917.htm 6-K 10139
2 EXHIBIT 99.1 exh_991.htm EX-99.1 319849
3 EXHIBIT 99.2 exh_992.htm EX-99.2 829
4 GRAPHIC logo.jpg GRAPHIC 4823
5 GRAPHIC graph.jpg GRAPHIC 37700
6 GRAPHIC proxy_01.jpg GRAPHIC 149079
7 GRAPHIC proxy_02.jpg GRAPHIC 108452
  Complete submission text file 0001171843-17-002931.txt   745380
Mailing Address 5955 AIRPORT ROAD, SUITE 228 MISSISSAUGA A6 L4V 1R9
Business Address 5955 AIRPORT ROAD, SUITE 228 . MISSISSAUGA A6 L4V 1R9 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 17831288
SIC: 2836 Biological Products, (No Diagnostic Substances)